YARW
Yarrow Bioscience Inc
NASDAQ · Healthcare · Biotechnology · US
$29.58
+2.53%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 135.67x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.58x
- Price / sales
- 163.84x
- Price / cash flow
- -4.66x
Enterprise value
- Enterprise value
- $56.0M
- EV / sales
- 116.28x
- EV / EBITDA
- -2.97x
- EV / EBIT
- -2.81x
- Market cap
- $79.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026